Malignant phyllodes tumor of the breast with heterologous osteosarcomatous and pleomorphic liposarcomatous differentiation: a rare case report and literature review
Abstract
Malignant phyllodes tumors (MPTs) of the breast account for approximately 8% to 20% of all phyllodes tumors (PTs) and represent a rare but clinically significant subtype of breast malignancy. Diagnosis is based on the histologic criteria of increased stromal cellularity, stromal overgrowth, cytologic atypia, elevated mitotic activity, and infiltrative tumor margins. MPTs may be associated with malignant heterologous elements, although most tumors exhibit a single component. The coexistence of two or more heterologous components is extremely rare. Herein, we report a case of malignant phyllodes tumor in a 60-year-old female, characterized by heterologous components of osteosarcoma and pleomorphic liposarcoma. We detail the treatment and outcomes, and present a literature review summarizing cases with two or more heterologous elements. This study aims to expand clinical understanding, elucidate the prognostic significance of heterologous component types, and inform the diagnosis and treatment of this rare entity.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.